Intellectual Property, Technology Transactions & FDA Regulatory Law Firm

Torrey Pines Law Group is an intellectual property (IP), technology transactions, and FDA regulatory law firm for artificial intelligence, software, semiconductor and life sciences companies and their investors. We opened our San Diego office in 2013, our Los Angeles and Irvine offices in 2020, our Boston office in 2024, and our Palo Alto office in 2026. Our patent preparation and prosecution, international technology transactions, and FDA regulatory practices serve companies from their first filing through acquisition or public offering, and we act as outside IP counsel to in-house legal teams. Chambers and Partners has recognized the firm for intellectual property in California in 2025 and 2026.

Chambers California 2026 Spotlight on Intellectual Property

Torrey Pines Law Group is proud to be recognized in the Chambers® California 2026 Spotlight Guide awarded through one of the most rigorous and selective processes in the legal industry, a distinction the firm has had since the inception of the award. Chambers & Partners®, widely regarded as the leading authority in law firm rankings, bases its evaluations on extensive research, client feedback, and peer interviews to identify firms that demonstrate exceptional technical ability, professionalism, and client service. As one of the few intellectual property law firms selected in California, this recognition highlights our expertise in cutting-edge fields such as artificial intelligence (AI), biotechnology, pharmaceuticals, medical devices, diagnostics, and high technology. We are honored by this acknowledgment and remain committed to supporting innovators from concept to market.

Our Exceptional Experience

Our team members have an average of 20 years of experience in the legal profession, and many are thought leaders in their scientific and technical fields as well as in their businesses and legal practices.

Most of our colleagues have experience embedded within large technology, pharmaceutical, biotechnology, and MedTech corporations. Many have held executive positions including General Counsel, Director, Officer, or other in-house executive positions inside publicly traded companies, agile startups, large universities, and government agencies.

Many of us are also active investors where we translate real-world experience into value-generating legal and business strategies. All of this exceptional experience fuels our ability to translate healthcare, life sciences, pharmaceutical, biotechnology, digital health, precision medicine, diagnostics, software, and high technology from concept to market.

Patent Preparation & Prosecution

Since our founding in 2013, our patent attorneys and patent agents have prepared and prosecuted patents worldwide at the intersection of artificial intelligence (AI), biotechnology, in vitro diagnostics (IVD), medical device, and pharmaceutical innovations. With the addition of a number of software, semiconductor, laser & optics, telecommunications, and telemedicine attorneys in 2024, our team has become a comprehensive resource to our clients innovating in the hardware, software, healthcare, life sciences, and convergence technology ecosystem.

We have also been selected by BCG as a Top San Diego IP Law Firm, and have been consistently selected by The Patent Lawyer magazine as one of the Top Ten West Coast IP and patent law firms.

Our clients include publicly traded companies, multinational companies, private and mid-sized technology and life sciences companies, major universities and private research institutes, venture-backed startups, and physician entrepreneurs. General counsel and heads of IP engage us as outside IP counsel.

International Technology Transactions

Our team is fluent in the languages of technology, business, and the law. We are able to successfully translate between those fields into actionable business strategies that impact your bottom line. In addition, we are business owners, investors, and entrepreneurs. We understand the day-to-day pressures and rewards that accompany high-level implementation of commercial strategy within innovative companies.

Our individual practitioners have successfully advised our clients through the maze of legal and commercial issues that arise in connection with the acquisition, development, adoption, and commercialization of new technologies and IP assets in a wide range of cutting-edge industries in the United States, Europe, and Asia.

Specifically, we are experts with drafting, negotiating and advising our clients with respect to international technology transactions, corporate strategy, business agreements, transactional due diligence, intellectual property agreements, intellectual property due diligence, regulatory agreements, and regulatory due diligence.

Our team structures and negotiates agreements and provides sophisticated business advice on the legal and commercial issues that arise in complex multijurisdictional technology and IP-related transactions, including mergers and acquisitions, patent licensing and valuation, SaaS, reseller, quality agreements, pharmacovigilance agreements, and development, collaboration, joint-venture, and distribution deals.

FDA Regulatory Counsel

Torrey Pines Law Group's regulatory attorneys and advisors have substantial experience providing global strategic advice regarding FDA regulatory, Digital Health laws, international privacy regulations, and public policy.

Our global FDA regulatory practice focuses on mitigating risk while also assessing the nuance between multijurisdictional markets which enhances the potential of a successful product launch.

Our team has substantial experience with all facets of the international regulatory approval and clearance processes including dossier submissions, Quality Compliance (ISO), CE Mark, MDR, Digital Health, Hatch-Waxman & Biosimilars, Labeling, Advertising & Promotion, and Reimbursement & Health Economics.

Experts in Go-To-Market Strategy

Each of our team leaders has more than 20 years of experience with technology commercialization.

We understand that the successful implementation of each of these solutions is required to provide value to your venture. These solutions also require thoughtful coordination, and our strategies are intended to evolve with your business goals. This integrated approach provides our clients the support they need to take their life sciences and healthcare products from concept to market.

What distinguishes us, however, is our ability to synthesize comprehensive go-to-market legal and business strategies. The foundation for our approach is understanding that the alignment of your R&D and/or clinical strategy, your IP strategy, your corporate strategy, commercial transactions, in addition to your regulatory and compliance strategy -- and so forth -- is critical to your business success. That arena is large and complex, and because we effectively translate between the languages of science, business, and the law, we are able to accomplish what few other law firms are able to accomplish.

Our firm focuses on coordinating the international aspects of the technology commercialization process including:

We welcome the opportunity to provide you more detailed information about our firm and see how we can work together. Please contact us to schedule a consultation.

Related topics: San Diego patent attorneys, Boston patent attorneys, Los Angeles patent attorneys, Palo Alto patent attorneys and IP, transactions and FDA FAQs.